Evidence map›Paper›PMID 33040071›Full record

ArticleHormone research in paediatrics2020

Unusual Glycemic Presentations in a Child with a Novel Heterozygous Intragenic INSR Deletion.

Federica Verdecchia, Nese Akcan, Antonia Dastamani, Kate Morgan, Robert K Semple, Pratik Shah

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Hormone research in paediatrics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Federica VerdecchiaEndocrinology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.
Nese AkcanEndocrinology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.
Antonia DastamaniEndocrinology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.
Kate MorganEndocrinology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom.
Robert K SempleCentre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Pratik ShahEndocrinology Department, Great Ormond Street Hospital for Children, NHS Foundation Trust, London, United Kingdom, pratik.shah6@nhs.net.
Great Ormond Street Hospital for Children NHS Foundation Trust · GBThe Queen's Medical Research Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMutations of the insulin receptor (INSR) gene lead to a wide spectrum of inherited insulin resistance (IR) syndromes. Among these, type A-IR, usually caused by dominant negative INSR mutations, generally presents peri-pubertally in girls. CASE: A 2.8-year-old girl was referred due to recurrent postprandial and fasting hypoglycemia. She had been born at full-term with birth weight 1.89 kg, and had developed transient neonatal diabetes. Examination showed satisfactory growth, reduced adipose tissue, acanthosis nigricans, and isolated thelarche. After 12 h of fasting, she developed hypoglycemia (glucose 2.8 mmol/L), with inappropriately raised plasma insulin concentration of 5.4 mU/L and suppressed fatty acids and ketone bodies. Oral glucose tolerance testing showed severely increased plasma insulin concentration (>300 mU/L) with hypoglycemia (glucose 1.6 mmol/L) at 2.5 h. She was initially managed on dietary modifications, cornstarch, and then trialed on acarbose for postprandial hyperinsulinemic hypoglycemia (PPHH) with some response. However, she was noted to have increased frequency of hyperglycemia after a couple of years of treatment. She was then switched to metformin and continued to have dietary carbohydrate modification including cornstarch that improved fasting tolerance, hyperglycemia, and postprandial hypoglycemia. Genetic testing identified heterozygous deletion of the last exon of the INSR gene, exon 22.

conclusionWe present a case of type A-IR, caused by a novel INSR deletion, presenting unusually early with transient neonatal diabetes, followed by episodes of hypoglycemia and hyperglycemia during later childhood. Early life presentations, including neonatal diabetes and PPHH, should lead to consideration of type A-IR.

Indexed as

Antigens, CDBlood GlucoseChild, PreschoolDiabetes MellitusDiagnosis, DifferentialFemaleGene DeletionGlucose Tolerance TestHeterozygoteHumansHyperinsulinismHypoglycemiaInsulin ResistanceReceptor, InsulinUnited KingdomAntigens, CDBlood GlucoseINSR protein, humanReceptor, InsulinHyperinsulismHypoglycemiaINSR geneInsulin resistanceNeonatal diabetesType A-IR

Identifiers

PMID33040071
PMCPMC7949216
OpenAlexW3092024142

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.